North America Intraoperative Neuromonitoring Market

Market Introduction

Intraoperative neuromonitoring (IONM) is an integral part of most of the surgical procedures. It has been widely used minimize neurological morbidity from operative manipulations, identify neural structures and thereby prevent post-operative impairments. The goal of such monitoring is to identify changes in spinal cord, brain, and peripheral nerve function prior to irreversible damage. IONM employs a wide range of modalities, which includes motor evoked potentials (MEPs), somatosensory evoked potentials (SSEPs), electroencephalography (EEG), electromyography, brainstem auditory evoked potentials (BAEPs), and visual evoked potentials (VEPs).

North America Intraoperative Neuromonitoring Strategic Insights

Strategic insights for the North America Intraoperative Neuromonitoring provides data-driven analysis of the industry landscape, including current trends, key players, and regional nuances. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. Leveraging data analytics, these insights help industry players anticipate the market shifts, whether investors, manufacturers, or other stakeholders. A future-oriented perspective is essential, helping stakeholders anticipate market shifts and position themselves for long-term success in this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the market.

North America Intraoperative Neuromonitoring Report Scope

North America Intraoperative Neuromonitoring Regional Insights

The geographic scope of the North America Intraoperative Neuromonitoring refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas.

The North America intraoperative neuromonitoring market is expected to reach US$ 1,874.02 million by 2027 from US$ 1,029.17 million in 2019. The market is anticipated to grow at a CAGR of 7.9% during 2019–2027. The rising incidences of neurological disorders and increasing technological advancements in the field of neuromonitoring are the major factors expected to boost the growth of the intraoperative neuromonitoring market in North America. However, the market is likely to get impacted by the risk factor such as dearth of skilled professional during the forecast period.

Key Market Segments

In terms of product, the systems segment accounted for the largest share of the North America intraoperative neuromonitoring market in 2019. In terms of source, insourced monitoring segment accounted for the largest share of the North America intraoperative neuromonitoring market  in 2019. In terms of modality, the somatosensory evoked potentials segment accounted for the largest share of the North America intraoperative neuromonitoring market in 2019. In terms of application, the spinal surgery segment accounted for the largest share of the North America intraoperative neuromonitoring market in 2019. In terms of end-user, the hospitals segment accounted for the largest share of the North America intraoperative neuromonitoring market in 2019.

Major Sources and Companies Listed

Several major primary and secondary sources associated with the North America intraoperative neuromonitoring market report are the World Health Organization (WHO), Centers of Disease Control and Prevention (CDC), Orthopaedic Research Society, Canadian Patient Safety Institute (CPSI), and American Association of Neurological Surgeons, among others.

Reasons to buy report

• It provides understanding of the North America, intraoperative neuromonitoring market landscape and identifies intraoperative neuromonitoring market segments that are most likely to guarantee a strong return.
• It guides stay ahead of the race by comprehending the ever-changing competitive landscape for the North America intraoperative neuromonitoring market.
• It helps efficiently plan merger and acquisition, and partnership deals in the intraoperative neuromonitoring market by identifying market segments with the most promising probable sales
• It facilitates knowledgeable business decision-making through perceptive and comprehensive analysis of intraoperative neuromonitoring market performance of various segments pertaining to the North America intraoperative neuromonitoring market.
• It provides intraoperative neuromonitoring market revenue forecast of the market based on various segments for the period from 2019 to 2027.

NORTH AMERICA INTRAOPERATIVE NEUROMONITORING MARKET SEGMENTATION

By Product

• Systems
• Accessories
• Services

By Source

• Insourced Monitoring
• Outsourced Monitoring

By Modality

• Motor Evoked Potentials
• Somatosensory Evoked Potentials
• Electroencephalography
• Electromyography
• Brainstem Auditory Evoked Potentials
• Visual Evoked Potentials

By Application

• Spinal Surgery
• Neurosurgery
• Vascular Surgery
• ENT Surgery
• Orthopedic Surgery
• Other Surgeries

By End User

• Hospitals
• Ambulatory Surgical Centers

By Country

• US
• Canada
• Mexico

Company Profiles

• Accurate Monitoring
• Computational Diagnostics, Inc
• IntraNerve Neuroscience Holdings, LLC
• Natus Medical Incorporated
• NuVasive, Inc
• SpecialtyCare
• Moberg Research, Inc